Conduit Pharmaceuticals Inc.

DB:ZK70 Stock Report

Market Cap: €1.4m

Conduit Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:ZK70 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Oct 24Sell€358,462Nirland LimitedCompany38,080€9.50
02 Oct 24Sell€269,517Nirland LimitedCompany26,000€10.87
17 Jul 24Sell€3,885,767Corvus CapitalCompany139,112.48€58.53
12 Jul 24Sell€314,920Corvus CapitalCompany13,898.2€22.66

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ZK70?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders59,5874.97%
Public Companies95,0457.93%
Institutions140,79311.7%
Private Companies153,50012.8%
VC/PE Firms302,26125.2%
General Public447,40037.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.6%.


Top Shareholders

Top 25 shareholders own 61.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.2%
Corvus Capital
302,261€343.5k0%no data
12.8%
Nirland Limited
153,500€174.5k0%no data
7.93%
AstraZeneca PLC
95,045€108.0k0%no data
3.35%
Presidio Property Trust, Inc.
40,153€45.6k0%100.0%
2.47%
Freda Lewis-Hall
29,583€33.6k17.4%no data
1.76%
Qube Research & Technologies Ltd
21,065€23.9k562%no data
1.67%
David Tapolczay
20,033€22.8k0%no data
1.08%
A.G.P. / Alliance Global Partners Corp.
13,000€14.8k0%91.75%
0.86%
Rhumbline Advisers Ltd Partnership
10,287€11.7k5,040%no data
0.74%
Barclays PLC Private Banking & Investment Banking Investment
8,923€10.1k6.51%no data
0.49%
Geode Capital Management, LLC
5,849€6.6k36.8%no data
0.45%
BlackRock, Inc.
5,397€6.1k-28.6%no data
0.44%
Citadel Advisors LLC
5,262€6.0k177%no data
0.31%
The Vanguard Group, Inc.
3,667€4.2k1.38%no data
0.29%
Chele Farley
3,515€4.0k572%no data
0.28%
Faith Charles
3,416€3.9k0%no data
0.27%
Jane Street Group, LLC, Asset Management Arm
3,279€3.7k0%no data
0.22%
Morgan Stanley, Investment Banking and Brokerage Investments
2,615€3.0k42.5%no data
0.17%
Simon Fry
2,000€2.3k0%no data
0.16%
Northern Trust Global Investments
1,861€2.1k0.7%no data
0.15%
Societe Generale, Securities Investments
1,760€2.0k331%no data
0.14%
FMR LLC
1,709€1.9k742%no data
0.14%
Two Sigma Securities, LLC, Asset Management Arm
1,679€1.9k0%no data
0.13%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,514€1.7k1,180%no data
0.11%
Goldman Sachs Group, Investment Banking and Securities Investments
1,312€1.5k159%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/21 07:19
End of Day Share Price 2025/01/28 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Conduit Pharmaceuticals Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.